CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228.1 USD | -0.86% |
|
-2.29% | -3.50% |
Chart calendar Charles River Laboratories International, Inc.
a0c32f5968b5f901409755191d72a07._gmsaDmtIafGQg-4IcNWgF5JNGjUrXzVvqIlvDMTFes.rEzuIkPDatXwEF7ea_QB9x9xfyDsxjWj9toWhEVJJbzOfJkAcp5Q_f4gOw~85cab5d39f91bd9615076d9a8e508fb3
Upcoming events on Charles River Laboratories International, Inc.
Past events on Charles River Laboratories International, Inc.
| 2024-05-09 08:30 am | Q1 2024 Earnings Call |
| 2024-05-09 07:00 am | Q1 2024 Earnings Release |
| 2024-05-08 08:00 am | Annual General Meeting |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Poster No:6181 |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Poster No:5467 |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Poster No:5315 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4703 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4413 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4224 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4191 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4186 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4182 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:3975 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Poster No:2841 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Poster No:2840 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Poster No:2835 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Poster No:2714 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Poster No:2630 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Poster No:2053 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Poster No:2020 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 621 2 614 0.28% | 2 924 2 891 1.15% | 3 540 3 522 0.52% | 3 976 3 915 1.56% | 4 129 4 107 0.54% | 4 220 |
|
EBITDA Million USD | Released Forecast Spread | 604 597 1.28% | 701 693 1.26% | 879 878 0.22% | 991 982 0.87% | 1 013 1 017 -0.4% | 1 062 |
|
EBIT Million USD | Released Forecast Spread | 497 489 1.64% | 585 575 1.73% | 742 738 0.51% | 834 820 1.67% | 839 842 -0.35% | 875 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 304 284 7.16% | 447 394 13.45% | 481 449 7.01% | 623 568 9.63% | 581 513 13.41% | 552 |
|
Net income Million USD | Released Forecast Spread | 252 240 4.84% | 364 296 23% | 391 358 9.2% | 486 409 18.85% | 475 387 22.66% | 411 |
|
EPS USD | Released Forecast Spread | 5,07 4,85 4.57% | 7,20 5,88 22.44% | 7,60 6,99 8.67% | 9,48 7,97 18.98% | 9,22 7,49 23.07% | 8,02 |
| Announcement Date | 11/02/20 | 17/02/21 | 16/02/22 | 22/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 914 909 0.58% | 973 995 -2.22% | 989 970 1.93% | 1 100 1 035 6.26% | 1 029 986 4.39% | 1 060 1 054 0.59% | 1 027 1 000 2.61% | 1 013 991 2.24% | 1 012 993 1.82% | 1 024 | 1 068 | 1 113 | 1 089 | 1 108 |
|
EBITDA Million USD | Released Forecast Spread | 233 233 0.02% | 250 247 1.36% | 240 238 1.14% | 267 260 2.72% | 260 252 3.03% | 260 258 0.62% | 255 241 5.8% | 239 242 -1.38% | 233 222 4.94% | 244 | 283 | 304 | 263 | 273 |
|
EBIT Million USD | Released Forecast Spread | 196 194 1.26% | 212 208 1.97% | 201 197 2.26% | 225 213 5.33% | 218 209 3.98% | 216 213 1.41% | 211 194 8.51% | 194 196 -1% | 187 178 5.43% | 198 | 235 | 255 | 221 | 230 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 111 149 -25.64% | 144 142 1.83% | 123 128 -3.67% | 245 155 57.85% | 131 150 -12.47% | 129 143 -10.32% | 113 120 -6.11% | 209 120 74.62% | 99,0 96,3 2.82% | |||||
|
Net income Million USD | Released Forecast Spread | 93,0 109 -14.63% | 109 110 -0.34% | 96,5 98,4 -1.95% | 187 109 71.19% | 103 102 0.7% | 97,0 105 -7.26% | 87,4 88,9 -1.74% | 187 92,4 102.53% | 67,3 71,2 -5.45% | 95,8 | 113 | 134 | 105 | 119 |
|
EPS USD | Released Forecast Spread | 1,81 2,07 -12.39% | 2,13 2,13 -0.04% | 1,88 1,84 2.12% | 3,65 2,14 70.86% | 2,01 1,99 0.87% | 1,89 2,04 -7.23% | 1,69 1,68 0.51% | 3,62 1,78 103.94% | 1,30 1,35 -3.7% | 1,80 | 2,25 | 2,63 | 2,02 | 2,28 |
| Announcement Date | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 11/05/23 | 09/08/23 | 08/11/23 | 14/02/24 | 09/05/24 | - | - | - | - | - |
| 2024-05-13 | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-15 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
Past sector events for Charles River Laboratories International, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRL Stock
- Calendar Charles River Laboratories International, Inc.
